Life Expectancy Has Improved With Childhood Type 1 DiabetesNewsJaapa
responsible for more than 1 million deaths each year. Cases of type 2 diabetes are increasing faster in developed countries such as the U.S. and Western Europe.
The new analysis shows, for example, that those with type 1 diabetes are living around 11 to 14 years less, on average, at the age of 20 to 24 years than those in the general population; this figure drops to 5 to 7 years less at age 65 to 69. In the past, life expectancy has ...
Loss of functional β-cell mass is the key mechanism leading to the two main forms of diabetes mellitus — type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). Understanding the mechanisms behind β-cell failure is critical to prevent or revert disease. Basic pathogenic differen...
Trial Registration clinicaltrials.gov Identifier: NCT00153101 In industrialized countries, as life expectancy increases and populations increase in age, type 2 diabetes mellitus and associated chronic kidney disease (CKD) have become major public health problems. Glycemic control, antihypertensive therapy, ...
They found that patients diagnosed with type 1 diabetes at 0 to 10 years of age had quadruple the risk of dying early from any cause compared with controls and were over seven times as likely to die from cardiovascular disease, leading to a loss in life expectancy of approximately 18 years...
The aim of the study was to examine the relationship between frailty level and quality of life in elderly individuals with Type 2 diabetes. This descriptive and correlational study was conducted with 211 patients who applied to the diabetes outpatient cl
Type 2 diabetes (T2D) is a disease characterized by heterogeneously progressive loss of islet β cell insulin secretion usually occurring after the presence of insulin resistance (IR) and it is one component of metabolic syndrome (MS), and we named it me
Millions of Indian adults are pre-diabetic with a greater risk of developing type-2 diabetes mellitus (T2DM). We conducted this study to assess the prevalence of type-2 diabetes risk among non-diabetic adults aged 45 years and above and identify the corr
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to